BLUE BIRD CORP (BLBD)

US0953061068 - Common Stock

35.4  +1.1 (+3.21%)

After market: 35.31 -0.09 (-0.25%)

Fundamental Rating

5

Taking everything into account, BLBD scores 5 out of 10 in our fundamental rating. BLBD was compared to 132 industry peers in the Machinery industry. BLBD has an average financial health and profitability rating. BLBD is evaluated to be cheap and growing strongly. This does not happen too often! With these ratings, BLBD could be worth investigating further for value and growth investing!.



5

1. Profitability

1.1 Basic Checks

BLBD had positive earnings in the past year.
BLBD had a positive operating cash flow in the past year.
In multiple years BLBD reported negative net income over the last 5 years.
In multiple years BLBD reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of BLBD (14.21%) is better than 92.25% of its industry peers.
BLBD's Return On Equity of 81.07% is amongst the best of the industry. BLBD outperforms 99.22% of its industry peers.
Looking at the Return On Invested Capital, with a value of 26.72%, BLBD belongs to the top of the industry, outperforming 98.45% of the companies in the same industry.
Industry RankSector Rank
ROA 14.21%
ROE 81.07%
ROIC 26.72%
ROA(3y)-2.3%
ROA(5y)0.72%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 5.04%, BLBD is in line with its industry, outperforming 53.49% of the companies in the same industry.
In the last couple of years the Profit Margin of BLBD has declined.
Looking at the Operating Margin, with a value of 8.20%, BLBD is in line with its industry, outperforming 48.84% of the companies in the same industry.
In the last couple of years the Operating Margin of BLBD has grown nicely.
Looking at the Gross Margin, with a value of 16.05%, BLBD is doing worse than 78.29% of the companies in the same industry.
BLBD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.2%
PM (TTM) 5.04%
GM 16.05%
OM growth 3Y22.15%
OM growth 5Y5.9%
PM growth 3Y14.85%
PM growth 5Y-5.7%
GM growth 3Y3.86%
GM growth 5Y0.59%

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BLBD is creating value.
BLBD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BLBD has been increased compared to 5 years ago.
Compared to 1 year ago, BLBD has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 5.50 indicates that BLBD is not in any danger for bankruptcy at the moment.
BLBD's Altman-Z score of 5.50 is fine compared to the rest of the industry. BLBD outperforms 78.29% of its industry peers.
The Debt to FCF ratio of BLBD is 1.51, which is an excellent value as it means it would take BLBD, only 1.51 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.51, BLBD belongs to the best of the industry, outperforming 83.72% of the companies in the same industry.
A Debt/Equity ratio of 1.72 is on the high side and indicates that BLBD has dependencies on debt financing.
BLBD has a Debt to Equity ratio of 1.72. This is amonst the worse of the industry: BLBD underperforms 89.15% of its industry peers.
Although BLBD does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 1.51
Altman-Z 5.5
ROIC/WACC2.89
WACC9.25%

2.3 Liquidity

BLBD has a Current Ratio of 1.30. This is a normal value and indicates that BLBD is financially healthy and should not expect problems in meeting its short term obligations.
BLBD's Current ratio of 1.30 is on the low side compared to the rest of the industry. BLBD is outperformed by 82.95% of its industry peers.
A Quick Ratio of 0.54 indicates that BLBD may have some problems paying its short term obligations.
BLBD's Quick ratio of 0.54 is on the low side compared to the rest of the industry. BLBD is outperformed by 86.82% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.54

7

3. Growth

3.1 Past

BLBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 267.65%, which is quite impressive.
Measured over the past years, BLBD shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.41% on average per year.
BLBD shows a strong growth in Revenue. In the last year, the Revenue has grown by 33.90%.
The Revenue has been growing slightly by 2.02% on average over the past years.
EPS 1Y (TTM)267.65%
EPS 3Y9.28%
EPS 5Y-8.41%
EPS growth Q2Q403.33%
Revenue 1Y (TTM)33.9%
Revenue growth 3Y8.81%
Revenue growth 5Y2.02%
Revenue growth Q2Q34.77%

3.2 Future

The Earnings Per Share is expected to grow by 50.28% on average over the next years. This is a very strong growth
Based on estimates for the next years, BLBD will show a quite strong growth in Revenue. The Revenue will grow by 12.53% on average per year.
EPS Next Y123.83%
EPS Next 2Y54.68%
EPS Next 3Y50.28%
EPS Next 5YN/A
Revenue Next Year11.85%
Revenue Next 2Y12.21%
Revenue Next 3Y12.53%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.53 indicates a correct valuation of BLBD.
Based on the Price/Earnings ratio, BLBD is valued a bit cheaper than 75.19% of the companies in the same industry.
BLBD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.28.
With a Price/Forward Earnings ratio of 13.83, BLBD is valued correctly.
Based on the Price/Forward Earnings ratio, BLBD is valued cheaper than 80.62% of the companies in the same industry.
BLBD's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.88.
Industry RankSector Rank
PE 15.53
Fwd PE 13.83

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLBD indicates a somewhat cheap valuation: BLBD is cheaper than 72.09% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BLBD is valued cheaply inside the industry as 88.37% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.67
EV/EBITDA 10.04

4.3 Compensation for Growth

BLBD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BLBD's earnings are expected to grow with 50.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y54.68%
EPS Next 3Y50.28%

0

5. Dividend

5.1 Amount

BLBD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUE BIRD CORP

NASDAQ:BLBD (5/3/2024, 7:00:01 PM)

After market: 35.31 -0.09 (-0.25%)

35.4

+1.1 (+3.21%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.14B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 15.53
Fwd PE 13.83
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 14.21%
ROE 81.07%
ROCE
ROIC
ROICexc
ROICexgc
OM 8.2%
PM (TTM) 5.04%
GM 16.05%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.82
Health
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.3
Quick Ratio 0.54
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)267.65%
EPS 3Y9.28%
EPS 5Y
EPS growth Q2Q
EPS Next Y123.83%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)33.9%
Revenue growth 3Y8.81%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y